Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
- Resource Type
- Source
- International Journal of Chronic Obstructive Pulmonary Disease
- Subject
Male Time Factors formoterol Muscarinic Antagonists Severity of Illness Index Pulmonary Disease, Chronic Obstructive Sex Factors aclidinium Forced Expiratory Volume Formoterol Fumarate Administration, Inhalation Humans Multicenter Studies as Topic COPD Adrenergic beta-2 Receptor Agonists Lung Aged Randomized Controlled Trials as Topic Original Research Age Factors Recovery of Function respiratory system Middle Aged respiratory tract diseases Bronchodilator Agents Drug Combinations Treatment Outcome Clinical Trials, Phase III as Topic Disease Progression Female circulatory and respiratory physiology Tropanes - Language
- ISSN
- 1178-2005